Floatz logo

Therapeutic Asset Ratings

8,400 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Axitinib
Breast Neoplasm
Lynkcell EuropeP1/2CCC (52)
Baclofen
Alcoholic Liver Cirrhosis
Corporacion Parc TauliP1/2CCC (52)
Bcma-Cart Cells
Plasma Cell Myeloma
Institute of Hematology & Blood Diseases Hospital, ChinaP1/2CCC (52)
bdb001
Advanced Solid Tumors
HighField Biopharmaceuticals CorporationP1/2CCC (52)
Bendamustine
Stage IV Prostate Cancer AJCC v8
Fred Hutchinson Cancer CenterP1/2CCC (52)
BIFIDOBACTERIUM LONGUM
Depressive Disorder
Shiraz University of Medical SciencesP1/2CCC (52)
BIFIDOBACTERIUM LONGUM
Depressive Disorder, Major Depressive Disorder
Shiraz University of Medical SciencesP1/2CCC (52)
Binimetinib
NRAS Gene Mutation
OnKure, Inc.P1/2CCC (52)
Black Chokeberry Extract In Capsules With 18% Standardization Of The Anthocyanins Content
Iron Deficiency Anemia
Poznan University of Physical EducationP1/2CCC (52)
Blinatumomab
Myeloid Leukemia
M.D. Anderson Cancer CenterP1/2CCC (52)
BMS-986345
T-cell Prolymphocytic Leukemia
Jonsson Comprehensive Cancer CenterP1/2CCC (52)
Calcium folinate pentahydrate
Acute Myeloid Leukemia
National Cancer Institute (NCI)P1/2CCC (52)
Calcium folinate pentahydrate
Diffuse Pleural Mesothelioma
Memorial Sloan Kettering Cancer CenterP1/2CCC (52)
Canagliflozin
Colorectal Cancer
West China HospitalP1/2CCC (52)
Capivasertib
Cutaneous Melanoma
Aminex Therapeutics, Inc.P1/2CCC (52)
Carbetocin
Obesity Disorder
Cairo UniversityP1/2CCC (52)
carbidopa
Multiple System Atrophy
Daniel ClaassenP1/2CCC (52)
Carboplatin
Uterine Cancer
University Health Network, TorontoP1/2CCC (52)
CARMUSTINE
Disease Related To Hematopoietic Stem Cell Transplant
Chinese PLA General HospitalP1/2CCC (52)
cd19-ucart
Childhood Acute Lymphoblastic Leukemia
University Hospital TuebingenP1/2CCC (52)
cd19-ucart
CLL
University Hospital TuebingenP1/2CCC (52)
cd22 car-transduced t cells
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer CenterP1/2CCC (52)
Cediranib
Lymphoplasmacytic Lymphoma
City of Hope Medical CenterP1/2CCC (52)
Cediranib
Metastatic Urothelial Carcinoma
M.D. Anderson Cancer CenterP1/2CCC (52)
Cetuximab
Solid Tumor, Adult
Verastem, Inc.P1/2CCC (52)
Showing 501 to 525 of 8,400 assets
PreviousPage 21 of 336Next